Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial

BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the ac...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurosurgery
Главные авторы: Fam, Maged D, Hanley, Daniel, Stadnik, Agnieszka, Zeineddine, Hussein A, Girard, Romuald, Jesselson, Michael, Cao, Ying, Money, Lynn, McBee, Nichol, Bistran-Hall, Amanda J, Mould, W Andrew, Lane, Karen, Camarata, Paul J, Zuccarello, Mario, Awad, Issam A
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Research—Human—Clinical Studies
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257031/
https://ncbi.nlm.nih.gov/pubmed/28402516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyx123
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы